SEC Comment Letter for BioCardia, Inc. (BCDA) (CIK 0000925741) (BCDA) — Sep 21, 2010

BioCardia, Inc. (BCDA) (CIK 0000925741)
Date: Sept. 21, 2010 · CIK: 0000925741 · Accession: 0000000000-10-055131

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-21419

Date

September 21, 2010

Author

Cc: Joshua Weingar d, Chief Legal Officer

Form

UPLOAD

Company

BioCardia, Inc. (BCDA) (CIK 0000925741)

Letter

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 DIVISION OF CORPORATION FINANCE Mail Stop 3030 September 21, 2010 Derrick Romine Chief Financial Officer Cardo Medical, Inc. 9701 Wilshire Blvd., Suite 1100 Beverly Hills, CA 90212 Re: Form 10-K for the fiscal year ended December 31, 2009 Filed September 29, 2008 File No. 000-21419

Dear Mr. Romine: We have completed our review of your Form 10-K and related filings and do not, at this time, ha ve any further comments.

Sincerely,
Brian Cascio Accounting Branch Chief
Cc: Joshua Weingar d, Chief Legal Officer

Show Raw Text

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

       DIVISION OF
CORPORATION FINANCE
Mail Stop 3030

September 21, 2010

 Derrick Romine Chief Financial Officer Cardo Medical, Inc.  9701 Wilshire Blvd., Suite 1100  Beverly Hills, CA    90212
 Re: Form 10-K for the fiscal year ended December 31, 2009
Filed September 29, 2008
File No.  000-21419

Dear Mr. Romine:
  We have completed our review of your Form 10-K and related filings
and do not, at this time, ha ve any further comments.

Sincerely,

 Brian Cascio Accounting Branch Chief
  Cc:  Joshua Weingar d, Chief Legal Officer

SecProbe.io